SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Rajshekhar Chakraborty, Prashant Kapoor, Stephen M Ansell, Morie A Gertz, Ibrutinib for the treatment of Waldenström macroglobulinemia, Expert Review of Hematology, 2015, 1

    CrossRef

  2. 2
    D Rizzo, J Chauzeix, F Trimoreau, J B Woillard, F Genevieve, A Bouvier, J Labrousse, C Poli, E Guerin, N Dmytruk, L Remenieras, J Feuillard, N Gachard, IgM peak independently predicts treatment-free survival in chronic lymphocytic leukemia and correlates with accumulation of adverse oncogenetic events, Leukemia, 2015, 29, 2, 337

    CrossRef

  3. You have free access to this content3
    Morie A. Gertz, Waldenström macroglobulinemia: 2015 update on diagnosis, risk stratification, and management, American Journal of Hematology, 2015, 90, 4
  4. 4
    Prashant Kapoor, Jonas Paludo, Nishanth Vallumsetla, Philip R. Greipp, Waldenström macroglobulinemia: What a hematologist needs to know, Blood Reviews, 2015,

    CrossRef

  5. 5
    Charlene M. McShane, Liam J. Murray, Eric A. Engels, Lesley A. Anderson, Community-acquired infections associated with increased risk of lymphoplasmacytic lymphoma/Waldenström macroglobulinaemia, British Journal of Haematology, 2014, 164, 5
  6. 6
    Masako Iwanaga, Chun-Ju Chiang, Midori Soda, Mei-Shu Lai, Ya-Wen Yang, Yasushi Miyazaki, Keitaro Matsuo, Tomohiro Matsuda, Tomotaka Sobue, Incidence of lymphoplasmacytic lymphoma/Waldenström's macroglobulinaemia in Japan and Taiwan population-based cancer registries, 1996–2003, International Journal of Cancer, 2014, 134, 1
  7. 7
    Alessandra Tedeschi, Anna Maria Frustaci, Paola Picardi, Enrica Morra, Overview on clinical trials in Waldenstrom's macroglobulinemia, Clinical Investigation, 2014, 4, 12, 1139

    CrossRef

  8. 8
    Leonard T Heffner, Waldenström macroglobulinemia at 70, International Journal of Hematologic Oncology, 2014, 3, 4, 253

    CrossRef

  9. 9
    Elisabet E. Manasanch, Sigurdur Y. Kristinsson, Ola Landgren, Etiology of Waldenström Macroglobulinemia: Genetic Factors and Immune-related Conditions, Clinical Lymphoma Myeloma and Leukemia, 2013, 13, 2, 194

    CrossRef

  10. 10
    Jorge Monge, Esteban Braggio, Stephen M. Ansell, Genetic Factors and Pathogenesis of Waldenström’s Macroglobulinemia, Current Oncology Reports, 2013, 15, 5, 450

    CrossRef

  11. 11
    Anita D'Souza, Stephen Ansell, Craig Reeder, Morie A. Gertz, Waldenström macroglobulinaemia: the key questions, British Journal of Haematology, 2013, 162, 3
  12. 12
    Morie A. Gertz, Waldenström macroglobulinemia: 2013 update on diagnosis, risk stratification, and management, American Journal of Hematology, 2013, 88, 8
  13. 13
    Siegfried Janz, Waldenström Macroglobulinemia: Clinical and Immunological Aspects, Natural History, Cell of Origin, and Emerging Mouse Models, ISRN Hematology, 2013, 2013, 1

    CrossRef

  14. 14
    Morie Gertz, Waldenström macroglobulinemia: my way, Leukemia & Lymphoma, 2013, 54, 3, 464

    CrossRef

  15. You have free access to this content15
    Morie A. Gertz, Waldenström Macroglobulinemia: 2012 update on diagnosis, risk stratification, and management, American Journal of Hematology, 2012, 87, 5